We are live on ! Find out more
NA

NVP Associates Portfolio holdings

AUM $176M
1-Year Est. Return 208.78%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+208.78%
3 Year Est. Return
+867.48%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$84.9M
Cap. Flow
+$81.9M
Cap. Flow %
46.5%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MBX
MBX Biosciences
MBX
+$48.9M
2
ZBIO
Zenas BioPharma
ZBIO
+$33.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 66.61%
2 Consumer Staples 15.41%
3 Technology 13.22%
4 Real Estate 4.76%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBX
1
MBX Biosciences
MBX
$2.95B
$55.5M 31.51%
+2,136,335
New +$48.9M
ZBIO
2
Zenas BioPharma
ZBIO
$1.92B
$31.1M 17.66%
+1,838,482
New +$33.1M
TALK icon
3
Talkspace
TALK
$873M
$30.7M 17.45%
14,702,972
– –
DAVE icon
4
Dave Inc
DAVE
$5.12B
$23.3M 13.22%
582,675
– –
UDMY
5
DELISTED
Udemy
UDMY
$23.2M 13.16%
3,114,732
– –
OPEN icon
6
Opendoor
OPEN
$3.69B
$8.38M 4.76%
4,329,214
– –
GROV icon
7
Grove Collaborative
GROV
$45M
$3.97M 2.26%
2,943,522
– –
DBGI
8
Digital Brands Group
DBGI
$7.41M
– –
0
– –

Similar funds

FF
Farrow Financial Randolph, Vermont $176M AUM 22.38% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
CWP
Cornerstone Wealth Partners Okemos, Michigan $176M AUM
RAS
RPS Advisory Solutions Louisville, Kentucky $176M AUM 22.27% 1-Year Est. Return
MFFIA
McIntyre, Freedman & Flynn Investment Advisers Orleans, Massachusetts $176M AUM 42.57% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
XWL
XXI Wealth LLC Chicago, Illinois $177M AUM

NVP Associates's Q3 2024 Portfolio in Review

As of Q3 2024, NVP Associates held 8 positions worth $176M, up 93% from $91.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NVP Associates deployed $81.9M of net new capital in Q3 2024, opening 2 new positions. Its largest new stake was MBX Biosciences: 2,136,335 shares worth $55.5M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Technology.

  • NVP Associates's largest Q3 2024 buy was MBX Biosciences: 2,136,335 shares worth $55.5M.
  • NVP Associates's ten largest holdings make up 100% of its $176M portfolio in Q3 2024.
  • NVP Associates opened 2 new positions and closed 0 in Q3 2024.
  • NVP Associates's portfolio value rose 93% quarter-over-quarter to $176M.

Based on NVP Associates's 13F filing for Q3 2024, filed 12 Nov 2024.